<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180828040897N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-21</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of immediate and delayed addition of nasal stent to nasoalveolar molding plate among patients with unilateral cleft lip and palate</public_title>
      <acronym></acronym>
      <scientific_title>Comparative evaluation of immediate and delayed addition of nasal stent to nasoalveolar molding plate on nostrils shape and cleft width among patients with unilateral cleft lip and palate</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/33678</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization based on blocking method, Blinding description: Patients are unaware to what intervention or control group they will be assigned.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Cleft palate. Condition 2: cleft lip.</hc_freetext>
      <i_freetext>Intervention 1: Control group: 10 patients with unilateral cleft of lip and palate are included.  First, all patients are referred to the proficient radiology scanner for facial scans, using proface software.  In this group, insertion of nasal stent into the nasoalveolar plaque is performed when the width of the cleft is 5 mm. Each week the plaques are adjusted with selective grinding and adding of elastic materials and the gap is measured monthly. The treatment continues for 2 months after insertion of the stent in each group, and ultimately the patients will be referred to the radiology clinic for a final scan of the face with the proface software. Intervention 2: Intervention group: 10 patients with unilateral cleft of lip and palate are included. First, all infants are referred to the proficient radiology scanner for facial scans, using proface software. In this group, insertion of nasal stent into the nasoalveolar plaque in the initial phase of the treatment occurs when the cleft width is greater than 5 mm. Each week the plaques are adjusted with selective grinding and adding of elastic materials and the gap is measured monthly. After 2 months of insertion of the stent, the infants will be referred to the radiology clinic for a final scan of the face with the proface software.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
A portion of the data, such as data on the main outcome or like that can be shared.

When:
Starting the access period 6 months after printing results

To whom:
own data will only be available to researchers working in academic and academic institutions

Conditions:
You have to completely control the data and get the credentials from the author.

Where to obtain:
Abdollah Jamalinasab. Email: abdollah jamalinasab@yahoo.com

How to obtain:
The requestor can contact by e-mail. Information is available as soon as possible

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Arezo Jahanbin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad Dental School, Vakilabad Blvd.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948959</zip>
        <telephone>+98 51 3883 2301</telephone>
        <email>abdollahjamalinasab@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arezo Jahanbin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad Dental School, Vakilabad Blvd.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948959</zip>
        <telephone>+98 51 3883 2301</telephone>
        <email>abdollahjamalinasab@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age under one month
Alveolar width greater than 6 mm
Parent's cooperation 
Informed consent</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>30 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Syndromic disease (patients)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Q35</hc_code>
      <hc_code>Q36</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cleft palate</hc_keyword>
      <hc_keyword>Cleft lip</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: 10 patients with unilateral cleft of lip and palate are included.  First, all patients are referred to the proficient radiology scanner for facial scans, using proface software.  In this group, insertion of nasal stent into the nasoalveolar plaque is performed when the width of the cleft is 5 mm. Each week the plaques are adjusted with selective grinding and adding of elastic materials and the gap is measured monthly. The treatment continues for 2 months after insertion of the stent in each group, and ultimately the patients will be referred to the radiology clinic for a final scan of the face with the proface software.</i_keyword>
      <i_keyword>Intervention group: 10 patients with unilateral cleft of lip and palate are included. First, all infants are referred to the proficient radiology scanner for facial scans, using proface software. In this group, insertion of nasal stent into the nasoalveolar plaque in the initial phase of the treatment occurs when the cleft width is greater than 5 mm. Each week the plaques are adjusted with selective grinding and adding of elastic materials and the gap is measured monthly. After 2 months of insertion of the stent, the infants will be referred to the radiology clinic for a final scan of the face with the proface software.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Columellar deviation angle: The intercalary angle that passes from the Clomarlar with the horizontal line in the subjective mental view of the radiograph. Timepoint: The beginning and the end of the treatment. Method of measurement: Using proface software (picture derived from software).</prim_outcome>
      <prim_outcome>Nostril width: The greatest distance between the clommler and the alar of nose in each side. Timepoint: The beginning and the end of the treatment. Method of measurement: Using proface software (picture derived from software).</prim_outcome>
      <prim_outcome>Nostril hight: the distance between the anteriormost point of the nasal cavity and the posterior part of the nose. Timepoint: The beginning and the end of the treatment. Method of measurement: Using proface software (picture derived from software).</prim_outcome>
      <prim_outcome>Inter comisural distance: the distance between the two corners of the lip. Timepoint: The beginning and the end of the treatment. Method of measurement: Using proface software (picture derived from software).</prim_outcome>
      <prim_outcome>Soft tissue cleft width: Maximum distance from the two edges of the cleft lip. Timepoint: The beginning and the end of the treatment. Method of measurement: Using proface software (picture derived from software).</prim_outcome>
      <prim_outcome>The nasal area is on the left and right side of the line from Nasion to Subnasal. Timepoint: The beginning and the end of the treatment. Method of measurement: Using proface software (picture derived from software).</prim_outcome>
      <prim_outcome>Clinical width of the gap. Timepoint: Weekly until the end of the study. Method of measurement: Use a caliper with a precision of 1 mm for.</prim_outcome>
      <prim_outcome>Width of the gap. Timepoint: Monthly until the end of the study. Method of measurement: Based on models scanned with Cone beam computed tomography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-10-28</approval_date>
        <contact_name>Ethics Committee of the Mashhad University of Medical Sciences</contact_name>
        <contact_address>Mashhad University of Medical Sciences, Vakil Abad Blvd. Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
